DK0914148T3 - Behandling af partielt væksthormonoverfølsomhedssyndrom - Google Patents

Behandling af partielt væksthormonoverfølsomhedssyndrom

Info

Publication number: DK0914148T3
Authority: DK; Denmark
Prior art keywords: growth hormone; patient; igf; serum level; below normal
Prior art date: 1996-05-03

Application number

DK97921307T

Other languages

English (en)

Inventor

Kenneth M Attie

Lena M S Carlsson

Neil Gesundheit

Audrey Goddard

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-03

Filing date

1997-04-18

Publication date

2003-11-24

1997-04-18 Application filed by Genentech Inc filed Critical Genentech Inc

2003-11-24 Application granted granted Critical

2003-11-24 Publication of DK0914148T3 publication Critical patent/DK0914148T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Diabetes (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

DK97921307T 1996-05-03 1997-04-18 Behandling af partielt væksthormonoverfølsomhedssyndrom DK0914148T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/643,212 US6207640B1 (en)	1994-04-07	1996-05-03	Treatment of partial growth hormone insensitivity syndrome
PCT/US1997/006652 WO1997041887A1 (en)	1996-05-03	1997-04-18	Treatment of partial growth hormone insensitivity syndrome

Publications (1)

Publication Number	Publication Date
DK0914148T3 true DK0914148T3 (da)	2003-11-24

Family

ID=24579841

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97921307T DK0914148T3 (da)	1996-05-03	1997-04-18	Behandling af partielt væksthormonoverfølsomhedssyndrom

Country Status (10)

Country	Link
US (1)	US6207640B1 (da)
EP (2)	EP1369125A1 (da)
JP (1)	JP2001510444A (da)
AT (1)	ATE246511T1 (da)
CA (1)	CA2252560C (da)
DE (1)	DE69723982T2 (da)
DK (1)	DK0914148T3 (da)
ES (1)	ES2205211T3 (da)
PT (1)	PT914148E (da)
WO (1)	WO1997041887A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080076706A1 (en)	1997-07-14	2008-03-27	Bolder Biotechnology, Inc.	Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US7495087B2 (en)	1997-07-14	2009-02-24	Bolder Biotechnology, Inc.	Cysteine muteins in the C-D loop of human interleukin-11
IL133974A0 (en)	1997-07-14	2001-04-30	Bolder Biotechnology Inc	Derivatives of growth hormone and related proteins
US8288126B2 (en)	1999-01-14	2012-10-16	Bolder Biotechnology, Inc.	Methods for making proteins containing free cysteine residues
NZ513077A (en) *	1999-01-14	2004-03-26	Bolder Biotechnology Inc	Methods for making proteins containing free cysteine residues
WO2004028568A1 (en) *	2002-09-27	2004-04-08	F. Hoffmann-La Roche Ag	Conjugates of insulin-like growth factor binding protein-4 and poly (ethylene glycol)
HUE027218T2 (en) *	2003-09-12	2016-10-28	Ipsen Biopharmaceuticals Inc	Methods for Treatment of IGF-1 (Insulin-like Growth Factor 1) Deficiency
CA2780554C (en) *	2009-11-17	2017-08-15	Ipsen Pharma S.A.S.	Formulation for hgh and rhigf-1 combination

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5126324A (en) *	1990-06-07	1992-06-30	Genentech, Inc.	Method of enhancing growth in patients using combination therapy
US5187151A (en) *	1991-02-12	1993-02-16	Genentech, Inc.	Use of binding protein with igf-i as an anabolic growth promoting agent
US5824642A (en) *	1994-04-07	1998-10-20	Genentech, Inc.	Treatment of partial growth hormone insensitivity syndrome
US5646113A (en)	1994-04-07	1997-07-08	Genentech, Inc.	Treatment of partial growth hormone insensitivity syndrome

1996
- 1996-05-03 US US08/643,212 patent/US6207640B1/en not_active Expired - Lifetime
1997
- 1997-04-18 CA CA2252560A patent/CA2252560C/en not_active Expired - Lifetime
- 1997-04-18 DE DE69723982T patent/DE69723982T2/de not_active Expired - Lifetime
- 1997-04-18 ES ES97921307T patent/ES2205211T3/es not_active Expired - Lifetime
- 1997-04-18 AT AT97921307T patent/ATE246511T1/de active
- 1997-04-18 DK DK97921307T patent/DK0914148T3/da active
- 1997-04-18 EP EP03011410A patent/EP1369125A1/en not_active Ceased
- 1997-04-18 PT PT97921307T patent/PT914148E/pt unknown
- 1997-04-18 EP EP97921307A patent/EP0914148B1/en not_active Expired - Lifetime
- 1997-04-18 WO PCT/US1997/006652 patent/WO1997041887A1/en not_active Ceased
- 1997-04-18 JP JP53993897A patent/JP2001510444A/ja active Pending

Also Published As

Publication number	Publication date
EP0914148A1 (en)	1999-05-12
JP2001510444A (ja)	2001-07-31
DE69723982D1 (de)	2003-09-11
ATE246511T1 (de)	2003-08-15
WO1997041887A1 (en)	1997-11-13
US6207640B1 (en)	2001-03-27
EP0914148B1 (en)	2003-08-06
DE69723982T2 (de)	2004-07-22
EP1369125A1 (en)	2003-12-10
PT914148E (pt)	2003-12-31
ES2205211T3 (es)	2004-05-01
CA2252560A1 (en)	1997-11-13
CA2252560C (en)	2010-12-14

Publication	Publication Date	Title
DK0754048T3 (da)	2001-11-05	Behandling af partielt væksthormon-insentivitetssyndrom
EP0476044A4 (en)	1992-07-01	Treating disorders by application of insulin-like growth factors and analogs
ATE82507T1 (de)	1992-12-15	Medizinische verwendung.
ES2101833T3 (es)	1997-07-16	Utilizacion de igf-i humano.
CA2334761A1 (en)	1999-12-29	Composition comprising .beta.-hydroxy-.beta.-methylbutyric acid and at least one amino acid and methods of use
DK0914148T3 (da)	2003-11-24	Behandling af partielt væksthormonoverfølsomhedssyndrom
DE69635305D1 (de)	2006-03-02	Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
HU9202092D0 (en)	1992-09-28	An implantate composition containing biologically active protein, peptide or polypeptide
EP0515434A4 (en)	1993-06-16	Method for treating intestinal diseases
DE69326122D1 (de)	1999-09-30	Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen
DE69433221D1 (de)	2003-11-13	Neues Chondrozytprotein
DE69113773D1 (de)	1995-11-16	Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma.
BR9006746A (pt)	1991-08-06	Peptideo fisiologicamente ativo e agente regulador do metabolismo de calcio